La cadena de opciones muestra datos clave de las opciones de acciones de CytoMed Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para CytoMed Therapeutics..

CytoMed Therapeutics (NASDAQ:GDTC) Bolsa, Cadena de Opciones

CytoMed Therapeutics

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics Ltd

Benchmark analyst Bruce Jackson reiterates CytoMed Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) with a Speculative Buy and maintains $5 price target.

News

Price Target

Reiteration

Analyst Ratings

GDTC

Benchmark Reiterates Speculative Buy on CytoMed Therapeutics, Maintains $5 Price Target

<ul>
<li>The acquisition includes (i) a cord blood banking licence issued by Malaysia's Ministry of Health, (ii) cryopreservation equipment with more than 12,000 cord blood units, and (iii) two freehold real estate properties totalling 189 square metres in which the operation is situated.</li>
<li>This acquisition will expand CytoMed's strategy in cell therapies as it now has access to rare and precious naïve cord blood donated for research and development. There are abundant clinical publications and evidence that cord blood offers a wide range of opportunities in the fields of regenerative medicine and aging diseases, including auto-immune diseases. This new biotechnology arm will be undertaken through CytoMed's subsidiary, LongevityBank Pte Ltd. The latter is the holding company of IPSC Depository Sdn Bhd which holds the cord blood banking licence issued by the Ministry of Health, Malaysia.</li>
</ul>

Health Care

General

CytoMed Therapeutics Has Acquired The License And Certain Assets Of Cellsafe International, A Malaysian Cord Blood Bank, Deal Terms Were Not Disclosed

WIIM

CytoMed Therapeutics shares are trading higher after the company announced that its subsidiary, IPSC Depository, acquired the license and certain assets of Cellsafe International for approximately $490,000 to be funded from internal cash resources.

Cytomed Therapeutics, Through Its Wholly Owned Subsidiary, IPSC Depository Acquired The Licence And Certain Assets Of Cellsafe International For A Cash Consideration Of About RM 2.3M Or $490,000 To Be Funded From Internal Cash Resources

Biotech

CytoMed Therapeutics Diversifies Into Regenerative Medicine After Research Collaboration With Singapore's Sengkang General Hospital

CytoMed Therapeutics Has Obtained Board Approval To Launch, Pilot Program To Isolate And Cryo-Store Peripheral Blood Mononuclear Cells For And As A Reward To Loyal Shareholders Of CytoMed On Complimentary Basis, The Program Will Commence On June 1, 2024

<a href="https://www.globenewswire.com/Tracker?data=Z3I3CabDDyTI5w5M__vI-QSXWV8XNAhKM46cTCP48WXblNKcBdRLdVTLWXb_HmB-EDP59YSnl6sJ2_MF_36kUxr7nrcVLqH-OTrYQzOyVYs=" target="_blank">CytoMed Therapeutics Limited</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) (&quot;CytoMed&quot; or &quot;Company&quot;), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic therapies for the treatment of various cancers and aging-related diseases, today announced that it has entered into a Research Collaboration Agreement (&quot;RCA&quot;) with Sengkang General Hospital Pte Ltd (&quot;SKH&quot;), a public hospital in Singapore and a member of the SingHealth group to establish proof-of-concept use of an injectable cartilage regeneration therapy that has been developed with donor-sourced, (allogeneic) umbilical cord-derived mesenchymal stem cells (&quot;UC-MSCs&quot;) to treat cartilage injury. This injectable therapy will be implemented&nbsp;in vivo&nbsp;to support the application and commencement of a proposed Phase 1 clinical trial in Singapore, and is anticipated to complete within two years.

CytoMed Therapeutics Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

<h3>Gainers</h3>
<ul>
<li>KalVista Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) stock moved upwards by 11.0% to $15.99 during Wednesday's after-market session. The market value of their outstanding shares is at $552.5 million. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) stock increased by 9.25% to $0.25. The company's market cap stands at $3.0 million. </li>
<li>CytoMed Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) stock rose 7.5% to $2.58. The market value of their outstanding shares is at $29.7 million. </li>
<li>Vaccinex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCNX#NASDAQ">VCNX</a>) stock rose 7.12% to $0.85. The market value of their outstanding shares is at $10.6 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares moved upwards by 6.66% to $1.68. The company's market cap stands at $6.1 million. </li>
<li>Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) stock increased by 6.55% to $0.72. The market value of their outstanding shares is at $65.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Adaptive Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) stock declined by 8.6% to $3.6 during Wednesday's after-market session. The market value of their outstanding shares is at $521.1 million. The company's, Q4 earnings came out today. </li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) stock fell 8.11% to $1.7. The market value of their outstanding shares is at $61.2 million. As per the news, the Q3 earnings report came out 2 days ago. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares fell 6.93% to $1.21. The company's market cap stands at $2.9 million. </li>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) shares decreased by 6.76% to $0.17. The company's market cap stands at $4.7 million. </li>
<li>Panbela Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) stock decreased by 6.62% to $1.27. The company's market cap stands at $4.4 million. </li>
<li>Acutus Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIB#NASDAQ">AFIB</a>) stock declined by 6.57% to $0.18. The market value of their outstanding shares is at $5.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ADPT

AFIB

AZTR

CDTX

KALV

OTRK

PBLA

TNON

VCNX

XAIR

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>NanoString Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSTG#NASDAQ">NSTG</a>) stock moved upwards by 26.9% to $0.15 during Friday's pre-market session. The company's market cap stands at $7.0 million. </li>
<li>TC BioPharm (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) stock rose 21.81% to $1.34. </li>
<li>OKYO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKYO#NASDAQ">OKYO</a>) stock increased by 21.32% to $1.74. The company's market cap stands at $57.6 million. </li>
<li>Corvus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVS#NASDAQ">CRVS</a>) shares moved upwards by 20.5% to $2.41. The market value of their outstanding shares is at $118.1 million. </li>
<li>CytoMed Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) stock rose 14.28% to $2.56. The market value of their outstanding shares is at $29.5 million. </li>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) stock increased by 11.76% to $0.19. The company's market cap stands at $5.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Synlogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYBX#NASDAQ">SYBX</a>) shares decreased by 52.2% to $1.65 during Friday's pre-market session. The company's market cap stands at $15.1 million. </li>
<li>BioXcel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) shares decreased by 35.47% to $2.42. The market value of their outstanding shares is at $72.4 million. </li>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) stock declined by 19.07% to $0.52. The company's market cap stands at $1.7 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) stock declined by 16.71% to $4.04. The company's market cap stands at $25.9 million. </li>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares fell 12.08% to $0.12. The market value of their outstanding shares is at $2.9 million. </li>
<li>Design Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGN#NASDAQ">DSGN</a>) stock fell 11.36% to $2.03. The company's market cap stands at $113.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BTAI

CRVS

DSGN

EVOK

NSTG

OKYO

SYBX

SYRA

TCBP

12 Health Care Stocks Moving In Friday's Pre-Market Session

Shares of The Container Store Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tcs#NYSE">TCS</a>) shares fell sharply during Wednesday&rsquo;s session following weak quarterly results.
Container Store Group posted adjusted loss of 8 cents per share, compared to market expectations for a loss of 5 cents per share. The company&rsquo;s quarterly sales came in at $214.90 million versus estimates of $220.72 million.
Container Store Group shares dipped 22.7% to $1.3150 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares jumped 400% to $7.51. The company announced it planned to join the Communications Industry Association. HOLO intends to join the Communications Industry Association to foster information technology innovation.</li>
<li>SMX (Security Matters) Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smx#NASDAQ">SMX</a>) shares climbed 138% to $0.5528.</li>
<li>Glatfelter Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/glt#NYSE">GLT</a>) climbed 68.8% to $2.1450 after the company and Berry Global announced they entered into definitive agreements for Berry to spin-off and merge the majority of its Health, Hygiene and Specialties segment to include its Global Nonwovens and Films business with Glatfelter.</li>
<li>MariaDB plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mrdb#NYSE">MRDB</a>) gained 57% to $0.3782 after jumping more than 26% on Tuesday.</li>
<li>ThermoGenesis Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thmo#NASDAQ">THMO</a>) climbed 37.7% to $0.8101.</li>
<li>Recon Technology, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcon#NASDAQ">RCON</a>) rose 33.3% to $0.1934.</li>
<li>Ault Alliance, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ault#NYSE">AULT</a>) surged 28.1% to $0.4549. Ault Alliance said it determined not to pursue new acquisitions during 2024, though it may continue to make strategic investments.</li>
<li>Luokung Technology Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lkco#NASDAQ">LKCO</a>) gained 27.4% to $0.6269.</li>
<li>MicroAlgo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlgo#NASDAQ">MLGO</a>) rose 27% to $0.4939.</li>
<li>Aviat Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avnw#NASDAQ">AVNW</a>) surged 23.7% to $37.20 after the company reported better-than-expected second-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>Jianpu Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jt#NYSE">JT</a>) gained 18.5% to $0.7584.</li>
<li>Enphase Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enph#NASDAQ">ENPH</a>) rose 17.7% to $118.36 after the company reported quarterly financial results.</li>
<li>Sonos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sono#NASDAQ">SONO</a>) gained 17.6% to $19.36 after the company reported better-than-expected quarterly financial results.</li>
<li>XPO, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpo#NYSE">XPO</a>) climbed 16.6% to $114.34 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Cirrus Logic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crus#NASDAQ">CRUS</a>) gained 15.1% to $90.28 after the company reported better-than-expected quarterly financial results.</li>
<li>Green Plains Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gpre#NASDAQ">GPRE</a>) climbed 14.6% to $22.94 following quarterly results.</li>
<li>Hitek Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hkit#NASDAQ">HKIT</a>) rose 14.1% to $0.81.</li>
<li>Griffon Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gff#NYSE">GFF</a>) gained 13.8% to $68.55 following upbeat results.</li>
<li>REGENXBIO Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgnx#NASDAQ">RGNX</a>) rose 13.3% to $14.78. Regenxbio has completed enrollment at dose level 2 and reported additional interim safety and efficacy in Phase 1/2 AFFINITY DUCHENNE trial of Rgx-202 in patients with Duchenne Muscular Dystrophy ages 4 to11 years old.</li>
<li>O-I Glass, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oi#NYSE">OI</a>) climbed 12.7% to $16.19 following upbeat results.</li>
<li>Frontier Group Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ulcc#NASDAQ">ULCC</a>) rose 11.3% to $6.93. Frontier reported fourth-quarter financial results and issued guidance.</li>
<li>Silicon Laboratories Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slab#NASDAQ">SLAB</a>) jumped 11.1% to $131.43 after the company reported better-than-expected quarterly financial results and issued guidance.</li>
<li>Griid Infrastructure Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grdi#NASDAQ">GRDI</a>) gained 10.9% to $2.35 after gaining over 4% on Tuesday.</li>
<li>Emerson Electric Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/emr#NYSE">EMR</a>) climbed 10.8% to $104.44 after the company reported better-than-expected quarterly earnings and raised FY24 outlook.</li>
<li>Yum China Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yumc#NYSE">YUMC</a>) shares rose 9.9% to $41.14 after the company reported fourth-quarter financial results and increased its dividend.</li>
<li>IHS Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ihs#NYSE">IHS</a>) gained 8.1% to $3.1250.</li>
<li>Fortinet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftnt#NASDAQ">FTNT</a>) rose 4% to $70.13 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) shares dipped 35.2% to $11.30 after the company reported mixed fourth-quarter results.</li>
<li>Sunworks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sunw#NASDAQ">SUNW</a>) shares fell 29.1% to $0.0617. Sunworks shares dipped 58% on Tuesday after the company announced it ceased operations and filed voluntary petitions for relief under the provisions of Chapter 7 of Title 11 of the United States Code.</li>
<li>CytoMed Therapeutics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdtc#NASDAQ">GDTC</a>) dipped 26.7% to $2.25.</li>
<li>fuboTV Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fubo#NYSE">FUBO</a>) shares fell 25.7% to $1.8650 after gaining around 4% on Tuesday.</li>
<li>Volcon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) tumbled 23.6% to $2.62.</li>
<li>The E.W. Scripps Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssp#NASDAQ">SSP</a>) fell 22.8% to $5.74.</li>
<li>MedAvail Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdvl#NASDAQ">MDVL</a>) shares declined 20.4% to $2.61 after jumping 92% on Tuesday.</li>
<li>Triumph Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgi#NYSE">TGI</a>) fell 18.8% to $13.35 after the company reported below-consensus third-quarter results and cut the FY24 outlook.</li>
<li>Perion Network Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/peri#NASDAQ">PERI</a>) fell 18.6% to $24.00 after the company issued worse-than-expected FY24 outlook.</li>
<li>ePlus inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plus#NASDAQ">PLUS</a>) shares declined 17.6% to $64.50 after the company reported worse-than-expected third-quarter results.</li>
<li>The Hain Celestial Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hain#NASDAQ">HAIN</a>) fell 16.9% to $9.42 after the company reported worse-than-expected quarterly revenue results.</li>
<li>Soho House &amp; Co Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shco#NYSE">SHCO</a>) fell 15.9% to $5.20.</li>
<li>KKR Real Estate Finance Trust Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kref#NYSE">KREF</a>) shares dipped 14.3% to $10.09 following fourth-quarter results.</li>
<li>Alpha and Omega Semiconductor Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aosl#NASDAQ">AOSL</a>) fell 14.1% to $22.11. The company reported second-quarter financial results and issued revenue guidance.</li>
<li>New York Community Bancorp, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NYSE">NYCB</a>) shares declined 12.8% to $3.6599. Fitch downgraded NYCB&rsquo;s long-term credit rating to one notch above non-investment grade at BBB-. Moody&rsquo;s downgraded NYCB&#39;s debt rating from Baa3 to Ba2.</li>
<li>Viasat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vsat#NASDAQ">VSAT</a>) fell 12.7% to $19.88 after the company reported quarerly financial results.</li>
<li>V.F. Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vfc#NYSE">VFC</a>) shares declined 12.2% to $14.88 after the company reported worse-than-expected third-quarter financial results.</li>
<li>Vestis Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsts#NYSE">VSTS</a>) fell 10.2% to $20.03 after the company reported worse-than-expected first-quarter sales results.</li>
<li>Rekor Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rekr#NASDAQ">REKR</a>) fell 9.5% to $2.7150 after the company announced the launch of a proposed follow-on public offering of common stock.</li>
<li>Berry Global Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bery#NYSE">BERY</a>) fell 9.2% to $58.35 after the company reported below-consensus first-quarter FY24 results and disclosed a deal for a tax-free spin-off and merger of Berry&#39;s Health.</li>
<li>Valley National Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vly#NASDAQ">VLY</a>) declined 8.3% to $7.49.</li>
<li>ADDvantage Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aey#NASDAQ">AEY</a>) fell 6.6% to $0.5790 after surging 77% on Tuesday.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/36983037/mckesson-earnings-are-imminent-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate"> McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts</a>

Penny Stocks

Small Cap

Intraday Update

Markets

Trading Ideas

AOSL

AULT

AVNW

BERY

CRUS

ENPH

FTNT

FUBO

GPRE

GRDI

HAIN

HKIT

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

KREF

LKCO

MDVL

MLGO

MRDB

NYCB

PERI

PLUS

RCON

REKR

RGNX

SHCO

SLAB

SNAP

SONO

SUNW

THMO

ULCC

VLCN

VSAT

VSTS

YUMC

Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>ThermoGenesis Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THMO#NASDAQ">THMO</a>) stock moved upwards by 39.0% to $0.86 during Wednesday's regular session. The market value of their outstanding shares is at $2.7 million. </li>
<li>Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) shares increased by 21.51% to $1.06. The company's market cap stands at $22.9 million. </li>
<li>PepGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEPG#NASDAQ">PEPG</a>) stock rose 13.77% to $12.1. The company's market cap stands at $288.1 million. </li>
<li>Abeona Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) shares rose 13.48% to $4.88. The company's market cap stands at $120.8 million. </li>
<li>FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) shares increased by 12.87% to $2.16. The market value of their outstanding shares is at $212.0 million. </li>
<li>Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) stock increased by 12.78% to $0.98. The company's market cap stands at $484.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CytoMed Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) stock declined by 29.3% to $2.17 during Wednesday's regular session. The market value of their outstanding shares is at $25.0 million. </li>
<li>Biolase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOL#NASDAQ">BIOL</a>) stock fell 25.69% to $0.38. The market value of their outstanding shares is at $1.3 million. </li>
<li>Elicio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) stock fell 18.69% to $3.09. The company's market cap stands at $29.6 million. </li>
<li>Biofrontera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) stock declined by 18.26% to $0.73. The company's market cap stands at $1.2 million. </li>
<li>Cingulate (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) shares declined by 17.04% to $1.07. The company's market cap stands at $1.5 million. </li>
<li>Cosmos Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COSM#NASDAQ">COSM</a>) stock fell 15.52% to $0.8. The company's market cap stands at $13.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABEO

BFRI

BIOL

CATX

CING

COSM

ELTX

FEMY

FGEN

PEPG

12 Health Care Stocks Moving In Wednesday's Intraday Session

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.25% to 38,618.79 while the NASDAQ rose 0.34% to 15,661.70. The S&amp;P 500 also rose, gaining, 0.34% to 4,971.18.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/36978503/top-5-energy-stocks-that-may-explode-in-february"> Top 5 Energy Stocks That May Explode In February</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Consumer discretionary shares rose by 0.7% on Wednesday.
In trading on Wednesday, utilities shares fell by 0.2%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Uber Technologies, Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uber#NYSE">UBER</a>) reported better-than-expected fourth-quarter sales.
Uber reported fourth-quarter FY23 revenue growth of 15% year-on-year to $9.94 billion, beating the consensus of $9.76 billion. Uber&rsquo;s GAAP EPS of $0.29 beat the consensus of $0.17.
Uber expects first-quarter gross bookings of $37.0 billion to $38.5 billion and an adjusted EBITDA of $1.26 billion to $1.34 billion.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares shot up 147% to $3.7007. MicroCloud Hologram said it is planning to join the Communications Industry Association.
Shares of Glatfelter Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/glt#NYSE">GLT</a>) got a boost, surging 82% to $2.3301 after the company and Berry Global announced they entered into definitive agreements for Berry to spin-off and merge the majority of its Health, Hygiene and Specialties segment to include its Global Nonwovens and Films business with Glatfelter.
SMX (Security Matters) Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smx#NASDAQ">SMX</a>) shares were also up, gaining 85% to $0.43.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Invitae Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvta#NYSE">NVTA</a>) shares dropped 33% to $0.06. Invitae, backed by SoftBank Group, is reportedly on the brink of filing for bankruptcy in the coming weeks.
Shares of CytoMed Therapeutics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdtc#NASDAQ">GDTC</a>) were down 34% to $2.03.
Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) was down, falling 32% to $11.90 after the company reported mixed quarterly results.
Also Check This Out:<a href="https://www.benzinga.com/news/24/02/36981099/spotify-to-rally-around-36-here-are-10-top-analyst-forecasts-for-wednesday"> Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.8% to $73.89 while gold traded up 0.1% at $2,053.80.
Silver traded down 0.2% to $22.435 on Wednesday while copper fell 0.5% to $3.763.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were lower today. The eurozone&rsquo;s STOXX 600 fell 0.1%, London&rsquo;s FTSE 100 fell 0.4% while Spain&rsquo;s IBEX 35 Index fell 0.8% The German DAX fell 0.3% French CAC 40 fell 0.1% while Italy&rsquo;s FTSE MIB Index fell 0.1%.
France&rsquo;s current account deficit shrank to EUR 0.7 billion in December versus a revised EUR 2.9 billion in the prior month, while trade deficit increased to &euro;6.83 billion in December from a &euro;5.9 billion gap in the previous month.
The Halifax House Price Index rose by 2.5% year-over-year in January, while German industrial output declined by 1.6% month-over-month in December.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.11%, Hong Kong&rsquo;s Hang Seng Index falling 0.34% and China&rsquo;s Shanghai Composite Index gaining 1.44%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, fell 0.06%.
China&#39;s vehicle sales climbed by 47.9% year-over-year to 2.44 million units in January. China&#39;s foreign exchange reserves fell to $3.219 trillion in January from $3.238 trillion in the prior month. Foreign exchange reserves in Hong Kong fell to $423.2 billion in January.
The index of leading economic indicators in Japan rose to 110.0 in December versus a revised reading of 108.1 in the previous month, while index of coincident economic indicators rose to 116.2 in December from a final reading of 114.6. Reserve assets in Japan declined to $1.292 trillion in January from $1.295 trillion a month ago.
&nbsp;
<h3>Economics</h3>
&nbsp;
US mortgage applications increased by 3.7% on the week ending Feb. 2.
The trade deficit in the US came in at $62.2 billion in December versus a revised $61.9 billion gap in November.
Now Read This: <a href="https://www.benzinga.com/news/24/02/36977073/wall-streets-most-accurate-analysts-hold-sell-these-3-tech-and-telecom-stocks-with-over-3-dividend-y"> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Tech And Telecom Stocks With Over 3% Dividend Yields </a>

Earnings

Eurozone

Commodities

Global

NVTA

UBER

US Stocks Gain; Uber Posts Upbeat Sales

<h3>Gainers</h3>
<ul>
<li>Societal CDMO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCTL#NASDAQ">SCTL</a>) shares moved upwards by 23.4% to $0.57 during Wednesday's pre-market session. The market value of their outstanding shares is at $59.7 million. </li>
<li>Apollomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLM#NASDAQ">APLM</a>) shares moved upwards by 19.86% to $0.7. The market value of their outstanding shares is at $62.3 million. </li>
<li>Elicio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares moved upwards by 17.89% to $4.48. The company's market cap stands at $43.0 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) shares increased by 14.34% to $0.55. The market value of their outstanding shares is at $2.3 million. </li>
<li>Renalytix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNLX#NASDAQ">RNLX</a>) shares rose 10.54% to $0.29. The company's market cap stands at $14.4 million. </li>
<li>PepGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEPG#NASDAQ">PEPG</a>) stock moved upwards by 10.1% to $11.71. The market value of their outstanding shares is at $278.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CytoMed Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) shares declined by 16.9% to $2.55 during Wednesday's pre-market session. The market value of their outstanding shares is at $29.3 million. </li>
<li>NanoString Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSTG#NASDAQ">NSTG</a>) shares decreased by 14.95% to $0.08. The market value of their outstanding shares is at $3.7 million. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) shares declined by 12.39% to $0.23. The company's market cap stands at $5.9 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) stock decreased by 10.62% to $0.64. The market value of their outstanding shares is at $5.5 million. </li>
<li>GRI Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRI#NASDAQ">GRI</a>) stock declined by 8.34% to $1.21. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) stock decreased by 7.76% to $2.26. The market value of their outstanding shares is at $6.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APLM

ALPS ETF Trusthen & Steers Global Realty Majors ETF

KZIA

OGEN

RNLX

SCNI

SCTL

XCUR

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Cytomed Therapeutics Announced That The Intellectual Property Corporation Of Malaysia Has Granted A Patent For Its Chimeric Antigen Receptor Gamma Delta T Cell Technology, Which Targets Solid And Hematological Tumors

<h3>Gainers</h3>
<ul>
<li>Jin Medical International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJYL#NASDAQ">ZJYL</a>) shares moved upwards by 19.2% to $93.0 during Monday's pre-market session. The company's market cap stands at $720.7 million. </li>
<li>Akso Health Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHG#NASDAQ">AHG</a>) stock moved upwards by 17.97% to $1.05. The market value of their outstanding shares is at $24.0 million. </li>
<li>CytoMed Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) stock increased by 14.78% to $4.97. The market value of their outstanding shares is at $57.3 million. </li>
<li>Regional Health Props (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RHE#AMEX">RHE</a>) stock rose 12.56% to $2.33. The market value of their outstanding shares is at $4.3 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock increased by 12.4% to $0.7. The market value of their outstanding shares is at $23.9 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock moved upwards by 11.2% to $0.89. The market value of their outstanding shares is at $2.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MAIA Biotechnology (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MAIA#AMEX">MAIA</a>) shares declined by 19.1% to $1.14 during Monday's pre-market session. The market value of their outstanding shares is at $19.3 million. </li>
<li>NewAmsterdam Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMS#NASDAQ">NAMS</a>) stock fell 18.18% to $14.0. The company's market cap stands at $1.1 billion. </li>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares fell 10.6% to $0.76. The market value of their outstanding shares is at $2.5 million. </li>
<li>Grifols (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRFS#NASDAQ">GRFS</a>) shares fell 8.92% to $7.25. The company's market cap stands at $4.9 billion. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) shares declined by 8.48% to $0.21. The company's market cap stands at $2.0 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares fell 7.81% to $1.3. The company's market cap stands at $4.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATNF

ENSC

GRFS

MAIA

NAMS

OCEA

YCBD

ZJYL

12 Health Care Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Cyclo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTH#NASDAQ">CYTH</a>) stock rose 34.1% to $2.2 during Wednesday's after-market session. The market value of their outstanding shares is at $50.0 million. </li>
<li>Cingulate (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) shares moved upwards by 22.05% to $4.87. The market value of their outstanding shares is at $4.5 million. </li>
<li>Virax Biolabs Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAX#NASDAQ">VRAX</a>) shares rose 10.69% to $1.76. The company's market cap stands at $3.1 million. </li>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) shares rose 8.64% to $0.37. The market value of their outstanding shares is at $3.3 million. </li>
<li>CytoMed Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) stock moved upwards by 7.69% to $5.6. The market value of their outstanding shares is at $64.5 million. </li>
<li>Nemaura Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRD#NASDAQ">NMRD</a>) shares moved upwards by 7.49% to $0.21. The company's market cap stands at $6.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Edgewise Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) stock decreased by 14.5% to $10.35 during Wednesday's after-market session. The company's market cap stands at $656.8 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) shares fell 9.64% to $3.0. The market value of their outstanding shares is at $65.6 million. </li>
<li>Panbela Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) stock decreased by 6.13% to $0.92. The market value of their outstanding shares is at $6.2 million. </li>
<li>Ampio Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMPE#AMEX">AMPE</a>) shares fell 5.91% to $2.07. The company's market cap stands at $1.7 million. </li>
<li>Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) shares fell 5.9% to $6.24. The company's market cap stands at $1.0 billion. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock declined by 5.77% to $0.57. The market value of their outstanding shares is at $1.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMPE

AUTL

CYTH

EWTX

NKGN

NMRD

NUWE

VRAX

<a href="https://w2.cytomed.sg/" target="_blank">CytoMed Therapeutics Limited</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDTC#NASDAQ">GDTC</a>) (&quot;CytoMed&quot; or &quot;Company&quot;), a&nbsp;Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced that it has entered into a Heads of Agreement (HOA) with CytoMed Therapeutics China Limited (CytoMed China), a company incorporated in&nbsp;Hong Kong&nbsp;and a Memorandum of Understanding (MOU) with BioNex Solutions Inc., 千尋生命科學.

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Financial Results for the Six Months Ended June 30, 2023
Net Loss: For the six months ended June 30, 2023, the Company's unaudited net loss amounted to S$1.16M ($860,695) excluding expenses related to its NASDAQ Initial Public Offering (IPO) in April 2023 and the costs associated with being a public listed company, compared to S$936,377 for the six months ended 2022.
Cash and Cash Equivalents: As of June 30, 2023, the Company had cash and cash equivalents of S$10.44M ($7.72M). Over the course of the last six months, the Company raised S$12.94M ($9.57M) gross proceeds from the IPO.
R&amp;D Expenses: The Company's research and development expenses were S$811,319 ($599,955) and S$604,043 for the six months ended June 30, 2023, and 2022, respectively. This was primarily due to the clinical progress achieved over the last six months.
G&amp;A Expenses: The Company's general and administrative expenses were S$1.50M ($1.11M) and S$306,457 for the six months ended June 30, 2023, and 2022, respectively. The increase was primarily driven by non-recurring IPO expenses and the costs associated with being a public listed company.

CytoMed Therapeutics Reports 1H 2023 Financial Report And Provides Corporate Update; Cash And Cash Equivalents: As Of June 30, 2023, The Company Had Cash And Cash Equivalents Of $7.72M

CytoMed Therapeutics Limited (GDTC) has released an update. CytoMed Therapeutics Limited announces a pilot program offering free cell banking to it...

CytoMed Launches Shareholder Cell Banking Program

Wall Street Breakfast: The Week Ahead

CytoMed Therapeutics Limited (GDTC) has released an update. CytoMed Therapeutics Limited is set to hold its Annual General Meeting (AGM) on May 15,...

CytoMed Therapeutics Announces Upcoming AGM

CytoMed Therapeutics Limited (GDTC) has released an update. CytoMed Therapeutics Limited successfully held its annual shareholders meeting, with ov...

CytoMed Therapeutics Reports Successful AGM

CytoMed Therapeutics Limited (GDTC) has released an update. CytoMed Therapeutics Limited has announced changes to its Board of Directors, with Dr. ...

CytoMed Announces Board Reorganization

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Friday as we check out all of the latest stories affecting shares on the last day of trading this week!



Moving stocks this morning are a Maui fire settlement report, a reverse stock split notice, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) stock is rocketing more than 68% with heavy trading after announcing <a href="https://www.nasdaq.com/press-release/presentation-times-and-schedule-participating-companies-now-posted-conference-website">a presentation yesterday</a>.</li>



<li>60 Degrees (NASDAQ:<a href="https://investorplace.com/stock-quotes/sxtp-stock-quote/">SXTP</a>) shares are soaring over 37% alongside strong early morning trading.</li>



<li>Hawaiian Electric Industries (NYSE:<a href="https://investorplace.com/stock-quotes/he-stock-quote/">HE</a>) stock is surging more than 37% on reports it included in the <a href="https://finance.yahoo.com/news/hawaiian-electric-among-firms-4-212211492.html">Maui fire settlement</a>.</li>



<li>Power REIT (NYSEMKT:<a href="https://investorplace.com/stock-quotes/pw-stock-quote/">PW</a>) shares are increasing over 23% without any apparent news.</li>



<li>Safe &amp; Green Development (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/">SGD</a>) stock is gaining more than 23% with strong pre-market trading.</li>



<li>Novo Integrated Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvos-stock-quote/">NVOS</a>) shares are rising over 22% on a <a href="https://www.businesswire.com/news/home/20240718621664/en/Novo-Integrated-Sciences-Receives-Commencement-of-Disbursement-Notice-for-SBLC-Leasing-and-Monetizing-Program">disbursement funds notice</a>.</li>



<li>Unicycive Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/uncy-stock-quote/">UNCY</a>) stock is climbing more than 15% despite a lack of news this morning.</li>



<li>Talphera (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlph-stock-quote/">TLPH</a>) shares are heading over 13% higher without any clear news to report.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is jumping close to 13% on Friday morning.</li>



<li>Sobr Safe (NASDAQ:<a href="https://investorplace.com/stock-quotes/sobr-stock-quote/">SOBR</a>) shares are up more than 12% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) stock is diving over 19% after <a href="https://www.prnewswire.com/news-releases/nauticus-robotics-announces-transformative-1-for-36-reverse-stock-split-302201004.html">announcing a reverse stock split</a>.</li>



<li>SunPower (NASDAQ:<a href="https://investorplace.com/stock-quotes/spwr-stock-quote/">SPWR</a>) shares are tumbling more than 17% after <a href="https://finance.yahoo.com/news/sunpower-plunges-halting-solar-installs-180816388.html">halting some of its operations</a>.</li>



<li>WaveDancer (NASDAQ:<a href="https://investorplace.com/stock-quotes/wavd-stock-quote/">WAVD</a>) stock is taking a nearly 14% beating on Friday morning.</li>



<li>CrowdStrike (NASDAQ:<a href="https://investorplace.com/stock-quotes/crwd-stock-quote/">CRWD</a>) shares are sliding over 13% <a href="https://www.cnbc.com/2024/07/19/crowdstrike-suffers-major-outage-affecting-businesses-around-the-world.html">alongside outages and issues</a>.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) stock is dropping more than 11% <a href="https://www.nasdaq.com/press-release/bionomics-initiates-affirm-1-phase-3-clinical-trial-bnc210-social-anxiety-disorder">following clinical trial results yesterday</a>.</li>



<li>Scholastic (NASDAQ:<a href="https://investorplace.com/stock-quotes/schl-stock-quote/">SCHL</a>) shares are decreasing over 11% with its <a href="https://www.benzinga.com/news/earnings/24/07/39849856/scholastic-shares-fall-after-worse-than-expected-q4-results-details">fiscal Q4 earnings report</a>.</li>



<li>Salarius Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/slrx-stock-quote/">SLRX</a>) stock is falling more than 10% after a major rally yesterday.</li>



<li>HighPeak Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/hpkew-stock-quote/">HPKEW</a>) shares are slipping over 10% this morning.</li>



<li>Super League Enterprise (NASDAQ:<a href="https://investorplace.com/stock-quotes/sle-stock-quote/">SLE</a>) stock is dipping almost 10% today.</li>



<li>CytoMed Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdtc-stock-quote/">GDTC</a>) shares are down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-19th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

CytoMed Therapeutics Limited (GDTC) has released an update. CytoMed Therapeutics Limited has released its unaudited interim condensed consolidated ...

CytoMed Therapeutics Reports Interim Financial Loss

CytoMed Therapeutics Limited reports 1H results

CytoMed Therapeutics Limited (GDTC) has released an update. CytoMed Therapeutics Limited has expanded its biopharmaceutical focus on cell-based the...

CytoMed Acquires Cord Blood Assets, Eyes Regenerative Medicine

CytoMed Therapeutics Limited (GDTC) has released an update. CytoMed Therapeutics Limited announced the initiation of the ANGELICA Trial, a Phase I ...

Comments

CytoMed Therapeutics

CytoMed Therapeutics (GDTC) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL